XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 24,222 $ 7,671
Restricted cash 50 4,151
Accounts receivable, net 458 366
Inventories 2,337 1,998
Prepaid expenses and other current assets 1,955 1,969
Total current assets 29,022 16,155
Property, plant and equipment, net 1,392 1,422
Right-of-use assets 185 285
Total assets 30,599 17,862
Current liabilities    
Accounts payable 2,428 2,018
Accrued expenses 7,120 4,685
Lease liabilities, current 93 186
Loan payable, current 3,770 7,846
Total current liabilities 13,411 14,735
Warrant liability 4,940
Other liabilities, non-current 1,158 1,144
Loan payable, non-current 992 3,070
Convertible notes payable, non-current 4,806 4,772
Total liabilities 25,307 23,721
Commitments and contingencies
Mezzanine equity    
Preferred F-1 stock, $.01 par value; 24,900 shares designated; 24,900 shares and 0 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 18,368 0
Stockholders' equity (deficit)    
Preferred stock, $.01 par value; 10,000,000 shares authorized; 11,357 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively
Common stock, $.01 par value; 40,000,000 shares authorized; 10,081,634 shares and 10,046,571 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 101 100
Additional paid-in capital 453,370 451,608
Accumulated deficit (466,483) (457,484)
Accumulated other comprehensive loss (64) (83)
Total stockholders' equity (deficit) (13,076) (5,859)
Total liabilities and stockholders' equity $ 30,599 $ 17,862